Comparison of methods for the detection of outliers and associated biomarkers in mislabeled omics data
暂无分享,去创建一个
Haixia Liu | Hongwei Sun | Yuehua Cui | Hui Wang | Tong Wang | Yuehua Cui | Hui Wang | Tong Wang | Hongwei Sun | Haixia Liu
[1] S. Wold,et al. The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses , 1984 .
[2] R. Jain,et al. Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers , 2017, Oncotarget.
[3] Federico Rotolo,et al. Empirical extensions of the lasso penalty to reduce the false discovery rate in high‐dimensional Cox regression models , 2016, Statistics in medicine.
[4] B. Nelson,et al. Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer , 2019, Scientific Reports.
[5] Chen Zhang,et al. Methods for labeling error detection in microarrays based on the effect of data perturbation on the regression model , 2009, Bioinform..
[6] N. Neamati,et al. Current Challenges and Opportunities in Treating Glioblastoma , 2018, Pharmacological Reviews.
[7] S. Sathiya Keerthi,et al. A simple and efficient algorithm for gene selection using sparse logistic regression , 2003, Bioinform..
[8] S. Sizemore,et al. GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2)* , 2014, The Journal of Biological Chemistry.
[9] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[10] J. Benítez,et al. VGLL1 expression is associated with a triple-negative basal-like phenotype in breast cancer. , 2014, Endocrine-related cancer.
[11] Jie Wu,et al. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] Niko Beerenwinkel,et al. Ensemble outlier detection and gene selection in triple-negative breast cancer data , 2018, BMC Bioinformatics.
[13] A. Hofman,et al. Loci at chromosomes 13, 19 and 20 influence age at natural menopause , 2009, Nature Genetics.
[14] Yukun Cui,et al. Forkhead box C1 boosts triple‐negative breast cancer metastasis through activating the transcription of chemokine receptor‐4 , 2018, Cancer science.
[15] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[16] G. Milhaud,et al. The complete sequence of human preprocalcitonin , 1984, FEBS letters.
[17] L. Maxim,et al. Screening tests: a review with examples , 2014, Inhalation toxicology.
[18] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[19] F. Zhou,et al. Epigenetic profiles capturing breast cancer stemness for triple negative breast cancer control. , 2019, Epigenomics.
[20] J. Mackey,et al. A fatty acid‐binding protein 7/RXRβ pathway enhances survival and proliferation in triple‐negative breast cancer , 2012, The Journal of pathology.
[21] E. Flores,et al. Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers , 2018, PloS one.
[22] Amos S Hundert,et al. Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1 , 2016, Oncotarget.
[23] Guansheng Zhong,et al. Identification of key genes as potential biomarkers for triple-negative breast cancer using integrating genomics analysis , 2019, Molecular medicine reports.
[24] R. D'Agostino. Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .
[25] Xuan Peng,et al. A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma , 1999, The Journal of experimental medicine.
[26] Ata Kabán,et al. Classification of mislabelled microarrays using robust sparse logistic regression , 2013, Bioinform..
[27] Madeleine Walker,et al. Masking unmasked , 2002, The Journal of audiovisual media in medicine.
[28] Shuangge Ma,et al. A selective review of robust variable selection with applications in bioinformatics , 2015, Briefings Bioinform..
[29] P. Rousseeuw,et al. Robust identification of target genes and outliers in triple-negative breast cancer data , 2018, Statistical methods in medical research.
[30] A. Naderi. SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies , 2018, Molecular oncology.
[31] N. Rezaei,et al. Integrative analyses of triple negative dysregulated transcripts compared with non‐triple negative tumors and their functional and molecular interactions , 2019, Journal of cellular physiology.
[32] John Elder,et al. Handbook of Statistical Analysis and Data Mining Applications , 2009 .
[33] Ailing Zhong,et al. Molecular profiling of mucinous epithelial ovarian cancer by weighted gene co-expression network analysis. , 2019, Gene.
[34] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[35] R. Tibshirani. Regression Shrinkage and Selection via the Lasso , 1996 .
[36] C. Haglund,et al. TUMORIGENESIS AND NEOPLASTIC PROGRESSION Astroprincin ( FAM 171 A 1 , C 10 orf 38 ) A Regulator of Human Cell Shape and Invasive Growth , 2018 .
[37] R. Santella,et al. Tumor expression of environmental chemical-responsive genes and breast cancer mortality. , 2019, Endocrine-related cancer.
[38] Stephen T. C. Wong,et al. Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer , 2013, Clinical Cancer Research.
[39] M J O'Hare,et al. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. , 2001, Cancer immunity.
[40] S. Efroni,et al. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer , 2014, Breast Cancer Research.
[41] Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer , 2019, Clinical & Experimental Metastasis.
[42] Hiroyuki Arai,et al. An Alternative Splicing Form of Phosphatidylserine-specific Phospholipase A1 That Exhibits Lysophosphatidylserine-specific Lysophospholipase Activity in Humans* , 1999, The Journal of Biological Chemistry.
[43] R. Geffers,et al. IPH‐926 lobular breast cancer cells are triple‐negative but their microarray profile uncovers a luminal subtype , 2013, Cancer science.
[44] J. H. Lee,et al. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. , 1997, Cancer research.
[45] Han-ning Li,et al. Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer , 2019, OncoTargets and therapy.
[46] Peter Filzmoser,et al. Robust and sparse estimation methods for high-dimensional linear and logistic regression , 2017, 1703.04951.
[47] Lindsay S. Cooley,et al. Metalloproteinase‐dependent and ‐independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs‐15 , 2015, International journal of cancer.
[48] M. Pencina,et al. On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data , 2011, Statistics in medicine.
[49] A. Ashworth,et al. Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. , 2015, Cancer discovery.
[50] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.
[51] T. Khoury,et al. Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer , 2013, Oncotarget.